Bio-Rad Laboratories Inc. (BIO)
NYSE: BIO
· Real-Time Price · USD
232.38
0.81 (0.35%)
At close: May 07, 2025, 3:59 PM
232.55
0.07%
After-hours: May 07, 2025, 04:09 PM EDT
0.35% (1D)
Bid | 228.27 |
Market Cap | 6.33B |
Revenue (ttm) | 2.54B |
Net Income (ttm) | -2.23B |
EPS (ttm) | -76.53 |
PE Ratio (ttm) | -3.04 |
Forward PE | 20.11 |
Analyst | Buy |
Ask | 236.27 |
Volume | 162,255 |
Avg. Volume (20D) | 389,836 |
Open | 235.66 |
Previous Close | 231.57 |
Day's Range | 230.22 - 236.15 |
52-Week Range | 215.38 - 387.99 |
Beta | 1.00 |
Analyst Forecast
According to 0 analyst ratings, the average rating for BIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 days ago
-1.5%
Bio-Rad Laboratories shares are trading higher aft...
Unlock content with
Pro Subscription
2 months ago
-1.92%
Bio-Rad Laboratories shares are trading lower after the company missed Q4 revenue estimates.

1 month ago · prismmediawire.com
Oncocyte Reports Successful 2024; Sets Stage for 2025 CatalystsIRVINE, Calif., March 24, 2025 – PRISM MediaWire – Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, today published the following letter to shareholders in conjunction with its fourth q...